Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pertti J Neuvonen

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Basic & Clinical Pharmacology & Toxicology|February 22, 2012
Towards safer and more predictable drug treatment--reflections from studies of the First BCPT Prize awardeePertti J Neuvonen
Duodecim; Laaketieteellinen Aikakauskirja|February 26, 2013
[Prediction and prevention of severe adverse effects and hazardous interactions of drugs]Pertti J Neuvonen
Current Opinion in Investigational Drugs (London, England : 2000)|February 24, 2010
Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogeneticsPertti J Neuvonen
European Journal of Clinical Pharmacology|May 8, 2014
Infections and possible vaccine-drug interactionsKari Raaska, Pertti J Neuvonen
Therapeutic Drug Monitoring|June 4, 2008
Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometryMikko Neuvonen, Pertti J Neuvonen
British Journal of Clinical Pharmacology|December 24, 2014
The role of concentration--effect relationships in the QTc interval prolongation: case sotalolPertti J Neuvonen, Erkki Elonen
Basic & Clinical Pharmacology & Toxicology|October 24, 2019
Sotalol, unlike the other beta-blockers, increases the QT<sub>c</sub> interval and risk of torsades de pointes ventricular tachycardia in severe poisoningsPertti J Neuvonen, Erkki Elonen
British Journal of Clinical Pharmacology|January 6, 2011
Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskirenTuija Tapaninen, Pertti J Neuvonen, Mikko Niemi
European Journal of Clinical Pharmacology|February 25, 2010
Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskirenTuija Tapaninen, Pertti J Neuvonen, Mikko Niemi
Obstetrics and Gynecology|December 2, 2005
Risks associated with selective serotonin reuptake inhibitors in pregnancyHeli Malm, Timo Klaukka, Pertti J Neuvonen
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Basic & Clinical Pharmacology & Toxicology|February 22, 2012
Towards safer and more predictable drug treatment--reflections from studies of the First BCPT Prize awardeePertti J Neuvonen
Duodecim; Laaketieteellinen Aikakauskirja|February 26, 2013
[Prediction and prevention of severe adverse effects and hazardous interactions of drugs]Pertti J Neuvonen
Current Opinion in Investigational Drugs (London, England : 2000)|February 24, 2010
Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogeneticsPertti J Neuvonen
European Journal of Clinical Pharmacology|May 8, 2014
Infections and possible vaccine-drug interactionsKari Raaska, Pertti J Neuvonen
Therapeutic Drug Monitoring|June 4, 2008
Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometryMikko Neuvonen, Pertti J Neuvonen
British Journal of Clinical Pharmacology|December 24, 2014
The role of concentration--effect relationships in the QTc interval prolongation: case sotalolPertti J Neuvonen, Erkki Elonen
Basic & Clinical Pharmacology & Toxicology|October 24, 2019
Sotalol, unlike the other beta-blockers, increases the QT<sub>c</sub> interval and risk of torsades de pointes ventricular tachycardia in severe poisoningsPertti J Neuvonen, Erkki Elonen
British Journal of Clinical Pharmacology|January 6, 2011
Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskirenTuija Tapaninen, Pertti J Neuvonen, Mikko Niemi
European Journal of Clinical Pharmacology|February 25, 2010
Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskirenTuija Tapaninen, Pertti J Neuvonen, Mikko Niemi
Obstetrics and Gynecology|December 2, 2005
Risks associated with selective serotonin reuptake inhibitors in pregnancyHeli Malm, Timo Klaukka, Pertti J Neuvonen
Pageof 20